Superworth

Utah Medical Products UTMD

Medical - Instruments & Supplies, Healthcare
$70.55
+3.64%
Market cap
$224.6M
PE
21.5×
10y median 20.9×
Forward PE
n/m
not a meaningful number
Price to sales
6.2×
EV/EBIT
4.8×
Revenue, 12 months
$36.1M
−7% on a year ago
Net margin
29.0%
Free cash flow yield
5.1%

Utah Medical Products trades at 21.5× trailing earnings, near its ten-year median. Revenue was $36.1M over the last twelve months, down 7% on a year earlier with a 29% net margin.

Charts

Financials

Income statement for UTMD, by quarter
Income statementQ3 FY23Q4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
$12.5M−4%$12.3M−9%$11.3M−9%$10.4M−19%$10M−20%$9.2M−26%$9.7M−14%$10M−4%$9.8M−2%$9M−1%$8.7M−10%$8.5M−14%
Cost of revenue$5.1M+8%$5.2M−0%$4.6M−2%$4.1M−19%$4.2M−18%$3.8M−27%$4.2M−9%$4.4M+5%$4.2M+0%$3.8M−1%$3.4M−18%$3.8M−14%
Gross profit$7.4M−10%$7.1M−15%$6.8M−14%$6.3M−19%$5.8M−21%$5.3M−25%$5.5M−18%$5.6M−11%$5.6M−3%$5.3M−1%$5.3M−5%$4.8M−15%
R&D$138K+23%$146K+19%$266K+85%$255K+92%$172K+25%$121K−17%$154K−42%$135K−47%$167K−3%$212K+75%$154K+0%$154K+14%
SG&A$3.3M+11%$3M−4%$2.6M−20%$2.6M−20%$2.3M−30%$2.3M−25%$2.2M−15%$2.3M−12%$2.8M+24%$2.6M+15%$2.6M+15%$2M−14%
$4M−23%$3.9M−22%$3.9M−13%$3.4M−22%$3.3M−16%$2.9M−26%$3.2M−19%$3.2M−7%$2.6M−22%$2.4M−17%$2.6M−19%$2.6M−17%
Pre-tax income$4.8M−11%$5M−10%$4.8M−6%$4.2M−19%$4.2M−13%$3.6M−28%$3.9M−20%$3.8M−9%$3.3M−21%$3.1M−14%$3.2M−18%$3.3M−14%
$846K−20%$731K−29%$842K−7%$758K−22%$616K−27%$712K−3%$817K−3%$788K+4%$678K+10%$540K−24%$578K−29%$600K−24%
Net income$3.9M−8%$4.3M−6%$4M−6%$3.5M−18%$3.6M−10%$2.9M−32%$3M−23%$3M−12%$2.6M−26%$2.6M−12%$2.6M−14%$2.7M−12%
$1.08−9%$1.18−6%$1.09−6%$0.98−15%$1.02−6%$0.86−27%$0.92−16%$0.94−4%$0.82−20%$0.80−7%$0.82−11%$0.84−11%
3.6M+0%3.6M+0%3.6M−1%3.5M−3%3.5M−4%3.4M−7%3.3M−9%3.2M−8%3.2M−8%3.2M−6%3.2M−4%3.2M−2%

EPS, diluted: Q4 FY10: quarter's net income to common over its shares, to the cent, the shares from counts implied by EPS, near the year's EPS less the nine months'. 7 periods, Q4 FY11 to Q4 FY17: quarter's net income to common over its shares, to the cent.

Diluted shares: 14 periods, Q4 FY11 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY17: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Instruments & Supplies nearest Utah Medical Products' size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
UTMDUtah Medical Products$224.6M21.5×20.9×6.2×−7%29.0%
PDEXPro DEX$184.5M15.9×16.5×2.3×+13%15.1%
INFUInfuSystem$275.7M33.8×43.5×1.9×+2%6.0%
EMBCEmbecta$350.7M4.2×11.6×0.3×−8%8.6%
TCMDTactile Systems Technology$518.1M21.2×62.3×1.5×+17%7.1%
KEQUKewaunee Scientific$96.7M12.1×13.6×0.3×+5%3.0%
MOVMovado$710.9M17.7×13.4×1.0×+5%6.0%
APTAlpha Pro Tech$56.3M13.5×14.8×0.9×+6%6.8%
IRMDIradimed$1B42.5×41.5×11.4×+11%26.8%
IARTIntegra Lifesciences$1.1B80.1×46.3×0.6×+1%0.8%
BVSBioventus$1.1B17.1×27.1×1.9×+4%9.4%
Peer median$434.4M17.4×21.8×1.3×+5%6.9%

More on Utah Medical Products

Each number over time

Where it ranks

Its groups

About

Industry
Medical - Instruments & Supplies
Sector
Healthcare

Valuation data, not investment advice. Prices as of .